Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2023, with a specific report date of January 18, 2023. The filing serves to distribute a press release regarding a significant intellectual property milestone for the Company's next-generation cryoablation systems.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or quantitative financial data.
Material Changes
The material change reported is the receipt of a Notice of Patent Allowance in Japan for a novel cryogenic pump. This development pertains to the Company's next-generation cryoablation systems and represents a regulatory and intellectual property advancement rather than a financial performance change.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward Looking Statements" section from the accompanying press release (Exhibit 99.1). The text does not explicitly detail specific financial guidance, management commentary on future performance, or a list of risks within the body of this Form 6-K, deferring to the incorporated press release for such disclosures.
Investor Verification Checklist
- Verify the scope and enforceability of the patent allowance received in Japan for the novel cryogenic pump.
- Review the full text of the press release (Exhibit 99.1) for specific forward-looking statements and associated risk factors.
- Confirm the timeline for the commercialization of the next-generation cryoablation systems utilizing this new pump technology.
- Check subsequent filings for any updates on the patent status or commercial impact of this allowance.